Riskpilot← Back to searchSign inGet full accessGULDSMED ApS
APSActiveCVR 31481791Nørrelund 37Buying and selling of own real estate · NACE 6811Est. 2008— employees
Revenue 2025
DKK -8K
+2% vs 2024
EBITDA margin
100.0%
-2% vs 2024
Equity ratio
-27.4%
Financial strength
Net profit 2025
DKK -8K
-2% vs 2024
| Revenue | DKK -8K | +2% |
| EBITDA | DKK -8K | -2% |
| Net profit | DKK -8K | -2% |
| Total assets | DKK 587K | +1% |
| Equity | DKK -161K | -5% |
| Employees | — | — |
Legal name
GULDSMED ApS
CVR number
31481791
Legal form
Anpartsselskab
NACE code
6811 · Buying and selling of own real estate
Founded
6. juni 2008
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af formanden for bestyrelsen sammen med et bestyrelsesmedlem
Company purpose
Selskabets formål er handel med fast ejendom og dermed beslægtet virksomhed
Address
Nørrelund 37
Phone
+4524900193
Email
orna@post.tele.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -58 | 129 | -9 | -7 | -8 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -58 | 129 | -9 | -7 | -8 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -58 | 129 | -9 | -7 | -8 |
| Net financials | -0 | -1 | 0 | 0 | 0 |
| Profit before tax | -59 | 128 | -9 | -7 | -8 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -59 | 128 | -9 | -7 | -8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 584 | 597 | 588 | 582 | 587 |
| Equity | -265 | -137 | -145 | -153 | -161 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 849 | 733 | 733 | 734 | 748 |
| Total debt | 849 | 733 | 733 | 734 | 748 |
EBITDA margin
-760700.0%
This company
15.8%
Market median
-4814657% vs market
20212025
Equity ratio
-27.4%
This company
38.2%
Market median
-172% vs market
20212025
Return on equity
-760700.0%
This company
18.4%
Market median
-4134339% vs market
20212025
Net profit margin
-760700.0%
This company
8.1%
Market median
-9391458% vs market
20212025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20212025
Debt / equity
4.65×
This company
0.62×
Market median
-650% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
OG Management | Management | 2008 – 2008 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2008 | |
| Individual | 15–19.99% | 15–19.99% | 2008 | |
| Individual | 15–19.99% | 15–19.99% | 2008 | |
| Individual | 15–19.99% | 15–19.99% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GULDSMED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Orla Guldsmed-Thomsen | Management | 0 companies |